PSC
9
6
6
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
0%
0 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (9)
Colangioids to Define the Genetic Factors Involved in Atypical Primary Sclerosing Cholangitis
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients
PET/MRI of Primary Sclerosing Cholangitis
Swiss Primary Sclerosing Cholangitis Cohort Study
Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation
A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.
Value of MRCP+ And Liver Multiscan in the Management of Dominant Strictures in Primary Sclerosing Cholangitis
Quantitative Magnetic Resonance Imaging in Biliary Disease: Health Economics Study